InvestorWire NewsRoom

InvestorNewsBreak

InvestorNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Announces Expansion of HealthTab(TM) Point-of-Care Testing Platform
August 8, 2022

InvestorNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Announces Expansion of HealthTab(TM) Point-of-Care Testing Platform

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) today announced that it is significantly expanding the number of Shoppers Drug Mart pharmacies offering its HealthTab(TM) point-of-care testing platform under a renewed master service agreement (“MSA”) to up to 450 locations nationwide. In addition to Shoppers Drug Mart pharmacies, the new MSA and corresponding statement of work (“SOW”) provides for affiliated locations under the Loblaw family of brands to utilize HealthTab upon request. The pilot of the HealthTab platform in 11 locations was announced in the summer of 2021 and, after initial success, more locations in Ontario were added, as well as five locations in British Columbia. “The results of the program so far have been fantastic and we’re very grateful to the hard-working pharmacy teams who have brought HealthTab to life,” said Hector Bremner, Avricore Health’s CEO. “Patient feedback showed that pharmacist’s capabilities are highly valued and having access to point-of-care data was seen as more supportive in their care, leading to better health outcomes.”

To view the full press release, visit https://ibn.fm/OjtvZ

About Avricore Health Inc.

Avricore Health is a pharmacy service innovator focused on acquiring and developing early stage technologies aimed at moving pharmacy forward. Through its flagship offering HealthTab(TM) (a wholly owned subsidiary), its mission is to make actionable health information more accessible to everyone by creating the world’s largest network of rapid testing devices in community pharmacies. For more information about the company, visit www.AvricoreHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).